Failure to address a global surplus of COVID vaccines raises the risk of new variants emerging, health experts warn

This post was originally published on this site

https://content.fortune.com/wp-content/uploads/2022/05/GettyImages-1236593404-e1652278413217.jpg

A global surplus of COVID-19 vaccines raises the risk of emerging variants | Fortune

You need to enable JavaScript to view this site.